对食道状细胞癌的新辅助尼沃卢马布治疗:单臂II期研究
Sehhoon Park1, Yurimi Lee2, Jiyun Lee1
1Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cancer research and treatment
|October 17, 2023
概括
新辅助尼沃卢马布治疗在可操作的食道状细胞癌 (ESCC) 中显示出适度的疗效. 需要对PD-L1表达ESCC的患者进行进一步的研究,以改善结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胃肠道瘤学 胃肠道瘤学
背景情况:
- 编程死亡-1/编程死亡-1 (PD-L1) 抑制剂对转移性食道状细胞癌 (ESCC) 有效.
- 关于可操作ESCC的新辅助免疫疗法的数据有限.
研究的目的:
- 评估新辅助尼沃卢马布治疗在可手术的ESCC患者中的疗效.
- 评估尼沃卢马布治疗后的主要病理反应 (MPR) 率.
主要方法:
- 20名患有临床阶段T2-T3 N0 ESCC的患者接受了三轮尼沃卢马布治疗.
- 主要终点是MPR率 (≤10%的残留可活性瘤[RVT]).
- 使用与免疫相关的标准 (irRVT) 重新评估了病理反应.
主要成果:
- 17名患者接受了手术;MPR率为11.8% (2/17).
- 使用与免疫相关的标准,17.6%的人实现了iMPR (≤10%的irRVT).
- PD-L1综合阳性得分 (CPS) ≥10预测iMPR (37.5%对CPS<10的0%相比).
结论:
- 新辅助药尼沃卢马布在未经选择的可手术ESCC患者中显示出适度的疗效.
- 对PD-L1表达ESCC患者进行进一步的研究是有必要的.
相关概念视频
Barrett Esophagus-II: Clinical Manifestations and Management
168
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
168
Esophageal Varices-II: Clinical Features and Management
73
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
73
Esophageal Strictures-II: Clinical Features and Management
78
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
78
Esophageal Varices-I: Introduction
154
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
154
Barrett Esophagus-I: Introduction
104
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
104
Esophagus
955
The esophagus, a muscular conduit linking the pharynx and stomach, measures roughly 10 inches (25.4 cm) and sits behind the trachea. It remains collapsed when not swallowing. The esophagus follows a predominantly straight path through the thoracic mediastinum and enters the abdominal cavity through a diaphragmatic opening known as the esophageal hiatus.
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
The movement of edibles from the pharynx into the esophagus is facilitated by the upper esophageal sphincter, which is formed primarily by the...
955


